Exabis Library
Welcome to the e-CCO Library!
P697: Examining the regulatory role of epigenetic and transcriptomic alterations in anti-TNF treatment response and disease progression in patients with Ulcerative Colitis
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM
P697: Thiopurines vs. anti-TNFa for the prevention of postoperative recurrence in Crohn’s disease—a meta-analysis
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P698 IBD patients equally tolerate bowel preparation but need higher doses of sedation during colonoscopy in comparison with a population screening programme: Results from a prospective, single-centre study 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P698: Early dose optimisation in non-responders to golimumab induction treatment for ulcerative colitis is supported by pharmacokinetic data
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P698: Mapping field cancerisation and clonal evolution in IBD colons with dysplasia and colorectal cancer
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM
P698: Persistence, clinical effectiveness and safety of vedolizumab in the post-marketing real clinical practice in Italy: a double-centre, 2-year experience in Crohn’s disease and ulcerative colitis patients 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P698: Role of an exclusion diet (reduced disaccharides, saturated fats, emulsifiers, red and ultraprocessed meats) in maintaining the remission of chronic inflammatory bowel diseases in adults
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:12 AM
P698: The risk of developing subsequent immune mediated inflammatory diseases: a retrospective matched cohort study
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P699 The concordance of Short Form-36 Health Survey scores with Mayo scores in the tofacitinib ulcerative colitis clinical programme 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P699: Faecal microbiota transplantation as treatment for recurrent clostridium difficile infections: a single-centre experience 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P699: Impact of adalimumab's patient support program on clinical outcomes in inflammatory bowel diseases: results from the COMPANION study
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P699: Machine Learning-based Prediction for Early Progression in Korean Crohn’s disease: Results from the IMPACT Study
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM
P699: Radiologic response reduces the risk of small-bowel surgery in Crohn’s disease
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P699: Ustekinumab therapy after biologic failure in patients with Crohn's Disease – A real-world single centre experience
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:12 AM
P700 Effect of vitamin D in disease activity score and clinical relapse in patients with inflammatory bowel disease: A systematic review and meta-analysis 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P700: A high CRP before surgery and early medical prophylaxis predict postoperative endoscopic Crohn’s disease recurrence
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P700: Epidemiology of genital lymphoedema as the initial presentation of paediatric Crohn's disease
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P700: Perceptions towards established and emerging dietary therapies for Crohn's disease management among the adult patients: results from a questionnaire survey
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:12 AM
P700: The efficacy of colesevelam to treat bile acid malabsorption in Crohn's disease: data from TOPPIC trial 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P700: The GEM Project: Stool metabolomic profile is associated with microbiome risk score and with future onset of Crohn’s disease in healthy first-degree relatives
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM